Progress with proton pump inhibition (Q35242583)

7 August 2017

3 references

2 October 2019

3 September 2020

30 January 2021

Progress with proton pump inhibition (English)

1 reference

7 August 2017

1 reference

2 October 2019

proton-pump inhibitor

2 references

3 September 2020

30 January 2021

Bell NJ

1

1 reference

7 August 2017

Hunt RH

series ordinal

2

1 reference

7 August 2017

publication date

1 November 1992

1 reference

Yale Journal of Biology and Medicine

7 August 2017

published in

3 references

7 August 2017

2 October 2019

3 September 2020

65

1 reference

7 August 2017

issue

6

1 reference

7 August 2017

page(s)

649-57;discussion 689-92

1 reference

Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

Healing and relapse of severe peptic esophagitis after treatment with omeprazole

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

No effect of omeprazole-induced hypoacidity on the bioavailability of amoxycillin or bacampicillin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

Omeprazole: pharmacokinetics and metabolism in man.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

Effect of omeprazole on gastric acid secretion and plasma gastrin in man.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

The gastric H ,K -ATPase: the site of action of omeprazole

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

Human gastric acid secretion following repeated doses of AG-1749.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

Elimination of Helicobacter pylori under treatment with omeprazole

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

The clinical safety of omeprazole

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

Gastrin and gastric enterochromaffin-like cell carcinoids in the rat.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

Partial gastric corpectomy results in hypergastrinemia and development of gastric enterochromaffinlike-cell carcinoids in the rat.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

Treatment of acid-related disorders with gastric acid inhibitors: the state of the art.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

Cure of duodenal ulcer after eradication of Helicobacter pylori

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

The cephalic and gastric phases of gastric secretion during H2-antagonist treatment

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

Activity of lansoprazole against Helicobacter pylori

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589777

26 September 2018

1 reference

12 December 2020

Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression

1 reference

12 December 2020

24-hour intragastric acidity and plasma gastrin after omeprazole treatment and after proximal gastric vagotomy in duodenal ulcer patients

1 reference

12 December 2020

Enterochromaffin-like cell carcinoids in the rat gastric mucosa following long-term administration of ranitidine

1 reference

12 December 2020

Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage

1 reference

12 December 2020

Oral pharmacokinetics of omeprazole

1 reference

12 December 2020

Studies on the mechanism of action of A80915A, a semi-naphthoquinone natural product, as an inhibitor of gastric (H -K )-ATPase

1 reference

12 December 2020

Australian clinical trials of omeprazole in the management of reflux oesophagitis

1 reference

12 December 2020

The relationship between suppression of acidity and gastric ulcer healing rates

1 reference

12 December 2020

Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole

1 reference

12 December 2020

Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion

1 reference

12 December 2020

Omeprazole (20 mg) daily given in the morning or evening: a comparison of effects on gastric acidity, and plasma gastrin and omeprazole concentration

1 reference

12 December 2020

Identifiers

PMC publication ID

2589777

1 reference

7 August 2017

1 reference